Atara Biotherapeutics Inc
NASDAQ:ATRA
ROA
Return on Assets
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
ROA Across Competitors
ROA Comparison
Atara Biotherapeutics Inc Competitors
Country | US |
Market Cap | 74m USD |
ROA |
-102%
|
Country | US |
Market Cap | 293.2B USD |
ROA |
4%
|
Country | US |
Market Cap | 141.2B USD |
ROA |
8%
|
Country | US |
Market Cap | 101.4B USD |
ROA |
18%
|
Country | US |
Market Cap | 98.2B USD |
ROA |
13%
|
Country | AU |
Market Cap | 131.7B AUD |
ROA |
7%
|
Country | US |
Market Cap | 82.3B USD |
ROA |
9%
|
Country | US |
Market Cap | 43.1B USD |
ROA |
-21%
|
Country | US |
Market Cap | 39.2B USD |
ROA |
-21%
|
Country | US |
Market Cap | 27.6B USD |
ROA |
5%
|
Country | IE |
Market Cap | 26.6B USD |
ROA |
5%
|
Profitability Report
View the profitability report to see the full profitability analysis for Atara Biotherapeutics Inc.
See Also
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
Based on Atara Biotherapeutics Inc's most recent financial statements, the company has ROA of -101.9%.